ACRO optimistic about ClinicalTrials.gov changes; Oxford spinout raises $16.1M for gene analysis;

> As federal regulators move to increase the amount of data that must be disclosed on ClinicalTrials.gov, CROs have some outstanding questions but are generally optimistic about the proposed changes, ACRO's John Lewis told Outsourcing-Pharma. More

> Genomics, an Oxford spinout offering genome data analysis, has raised $16.1 million to develop its platform. News